Results
1 -
10 of
11Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes, Cardiovascular Diabetology Anagliptin increases insulin-induced skeletal muscle glucose uptake via an NO-dependent mechanism in mice, Diabetologia Effect of Anagliptin and Sitagliptin in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: What Is the Real REASON Behind It?, Cardiovascular Drugs and Therapy Recent package insert revisions recommended by PMDA, Reactions Weekly Pharmacokinetic disposition of anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in rats and dogs, European Journal of Drug Metabolism and Pharmacokinetics Additive Effects of Miglitol and Anagliptin on Insulin-Treated Type 2 Diabetes Mellitus: A Case Study, Clinical Drug Investigation Anagliptin, Reactions Weekly CD26 antigen inhibitors, Reactions Weekly The effect of anagliptin treatment on glucose metabolism and lipid metabolism, and oxidative stress in fasting and postprandial states using a test meal in Japanese men with type 2 diabetes, Endocrine